EVI2B, a Gene Lying in an Intron of the Neurofibromatosis Type 1 (NF1) Gene, Is As the NF1 Gene Involved in Differentiation of Melanocytes and Keratinocytes and Is Overexpressed in Cells Derived from NF1 Neurofibromas

Kaufmann, Dieter; Gruener, Susanne; Braun, Friederike; Stark, Markus; Griesser, Johann; Hoffmeyer, Sven; Bartelt, Britta
May 1999
DNA & Cell Biology;May99, Vol. 18 Issue 5, p345
Academic Journal
The EVI2B gene is one of three genes embedded in intron 27b of the neurofibromatosis type 1 (NF1; M. Recklinghausen) gene, which are transcribed in the direction opposite that of the NF1 gene. The function of EVI2B and its relation to NF1 symptoms is unknown. Here, the amounts of NF1 and EVI2B mRNA were investigated in detail in cells involved in NF1 manifestations as cafe-au-lait macules and neurofibromas. These investigations showed that aside from the NF1 gene, EVI2B is involved in melanocyte and keratinocyte differentiation. Whereas in NF1 melanocytes from cafe-au-lait macules, EVI2B expression was not altered, in fibroblast-like cells derived from neurofibromas, an increased level of EVI2B mRNA was found. We investigated whether this increase was attributable to an influence of NF1 gene expression on the expression of the EVI2B gene, as suggested by the fact that the EVI2B primary transcript is antisense to the NF1 primary transcript. Investigations of cells derived from patients with different amounts of NF1 pre-mRNA showed no correlation between the amount of NF1 pre-mRNA and the increased level of EVI2B mRNA.


Related Articles

  • Neurofibromatosis 1 (Recklinghausen Disease) and Neurofibromatosis 2 (Bilateral Acoustic Neurofibromatosis). Mulvihill, John J.; Parry, Dilys M.; Sherman, John L.; Pikus, Anita; Kaiser-Kupfer, Muriel I.; Eldridge, Roswell // Annals of Internal Medicine;7/1/90, Vol. 113 Issue 1, p39 

    Provides information on neurofibromatosis 1 and neurofibromatosis 2. Nomenclature and history; Overview of diagnostic criteria for the neurofibromatoses; Application of gene mapping to understand the pathogenesis of each condition and develop effective therapies.

  • Interdomain binding mediates tumor growth suppression by the NF2 gene product. Sherman, Larry; Xu, Hua-Mei; Geist, Robert T; Saporito-Irwin, Susan; Howells, Norma; Ponta, Helmut; Herrlich, Peter; Gutmann, David H // Oncogene;11/13/97, Vol. 15 Issue 20, p2505 

    The neurofibromatosis 2 (NF2) tumor suppressor gene encodes an intracellular membrane-associated protein, called merlin (or schwannomin), that belongs to the band 4.1 family of cytoskeleton-associated proteins. Inactivating NF2 mutations occur in several sporadic tumor types and have been linked...

  • The different forms of neurofibromatosis. Huson, Susan M. // British Medical Journal (Clinical Research Edition);5/2/1987, Vol. 294 Issue 6580, p1113 

    Examines the different forms of neurofibromatosis. Features of the disease; Report on gene mapping progress responsible for the forms of neurofibromatosis; Use of polymorphic DNA markers on localization study on gene for von Recklinghausen neurofibromatosis; Applicability of DNA markers on...

  • Study Finds Link Between Common Neurological Disorder and Alzheimer's Disease.  // Ascribe Newswire: Medicine;8/21/2002, p2 

    A new study links the genes responsible for neurofibromatosis, a common neurological disorder, to a protein thought to play a role in Alzheimer's disease. The protein shared by neurofibromatosis and Alzheimer's disease is kinesin-1. The two genes linked to the disease are neurofibromin (NF1) and...

  • Histogenesis control genes and neurofibromatosis 1. Riccardi, Vincent M. // European Journal of Pediatrics;2000, Vol. 159 Issue 7, p475 

    Discusses the genetic disorder neurofibromatosis (NF). Usefulness of a tumor suppressor gene in NF; Contribution of NF gene to wound in a neurologic tissue; Description of NF gene.

  • Deletions of NF1 gene and exons detected by multiplex ligation-dependent probe amplification. De Luca, A.; Bottillo, I.; Dasdia, M. C.; Morella, A.; Lanari, V.; Bernardini, L.; Divona, L.; Giustini, S.; Sinibaldi, L.; Novelli, A.; Torrente, I.; Schirinzi, A.; Dallapiccola, B. // Journal of Medical Genetics;Dec2007, Vol. 44 Issue 12, p800 

    To estimate the contribution of single and multi-exon NF1 gene copy-number changes to the NF1 mutation spectrum, we analysed a series of 201 Italian patients with neurofibromatosis type 1 (NF1). Of these, 138 had previously been found, using denaturing high-performance liquid chromatography or...

  • Germline SMARCB1 mutation and somatic NF2 mutations in familial multiple meningiomas. Christiaans, I.; Kenter, S. B.; Brink, H. C.; van Os, T. A. M.; Baas, F.; van den Munckhof, P.; Kidd, A. M. J.; Hulsebos, T. J. M. // Journal of Medical Genetics;Feb2011, Vol. 48 Issue 2, p93 

    Background Multiple meningiomas occur in <10% of meningioma patients. Their development may be caused by the presence of a predisposing germline mutation in the neurofibromatosis type 2 (NF2) gene. The predisposing gene in patients with non-NF2 associated multiple meningiomas remains to be...

  • BRAF Gene Deletion Broadens the Clinical Spectrum Neuro-Cardio-Facial-Cutaneous Syndromes. Yu, Shihui; Graf, William D. // Journal of Child Neurology;Dec2011, Vol. 26 Issue 12, p1593 

    Point mutations in the human BRAF gene are associated with a group of heterogeneous autosomal dominant neuro-cardio-facial-cutaneous syndromes. We identified a novel 93 kb intragenic deletion of the BRAF gene in a boy with severe developmental encephalopathy using microarray-based comparative...

  • A G→A transition creates a branch point sequence and activation of a cryptic exon, resulting in the hereditary disorder neurofibromatosis 2. De Klein, Annelies; Riegman, Peter H.J.; Bijlsma, Emilia K.; Heldoorn, Anneliek; Muijtjens, Manja; den Bakker, Michael A.; Avezaat, Cees J.J.; Zwarthoff, Ellen C. // Human Molecular Genetics;Mar1998, Vol. 7 Issue 3, p393 

    Describes the G to A transition within intron 5 of the neurofibromatosis type 2 gene resulting to hereditary disorder neurofibromatosis 2. Impact of gene inactivation in tumor formation; Formation of the mammalian splice imtermediate; Clinical manifestations of the disease; Incorporation of an...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics